Vimarsana
Biggest News Aggregation in the World

Predict Optimized Treatment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Predict Optimized Treatment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Predict Optimized Treatment Today - Breaking & Trending Today

Cognitive Biotype, New Depression Subtype, Resistant to Common Antidepressants - Vimarsana News

Cognitive Biotype, New Depression Subtype, Resistant to Common Antidepressants

A new subtype of depression, the cognitive biotype, affects 27% of patients with depression who respond poorly to prescribed antidepressants.

Cognitive Biotype, New Depression Subtype, Resistant to Common Antidepressants - Vimarsana News

Cognitive Biotype, New Depression Subtype, Resistant to Common Antidepressants

A new subtype of depression, the cognitive biotype, affects 27% of patients with depression who respond poorly to prescribed antidepressants.

Cognitive Biotype: A Novel Depression Subcategory Defying Conventional Treatments Identified - Vimarsana News

Cognitive Biotype: A Novel Depression Subcategory Defying Conventional Treatments Identified

Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants.

Fewer Benzos Prescribed to Kids; Teva Liable for Opioid Crisis; Food Addictions? - Vimarsana News

Fewer Benzos Prescribed to Kids; Teva Liable for Opioid Crisis; Food Addictions?

News and commentary from the psychiatry world

Total Brain Licenses iSPOT-D for Depression Research - Vimarsana News

Total Brain Licenses iSPOT-D for Depression Research

/PRNewswire/ -- Total Brain today announced that the company will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D)...